DOI:
10.1055/s-00032260
Digestive Disease Interventions
LinksClose Window
References
Fuchs CS, Doi T, Jang RW. et al.
Safety and efficacy of pembrolizumab monotherapy in patients with previously treated advanced gastric and gastroesophageal junction cancer: phase 2 clinical KEYNOTE-059 trial.
JAMA Oncol 2018;
4 (05) e180013
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.